Tacalcitol

Chemical formula: C₂₇H₄₄O₃  Molecular mass: 416.646 g/mol 

Pregnancy

The safety of this medicinal product for use in human pregnancy has not been established. Evaluation of experimental animal studies does not indicate direct or indirect harmful effects with respect to the development of the embryo or foetus, the course of gestation or peri- or postnatal development. Avoid use in pregnancy unless there are no safer alternatives.

Nursing mothers

During lactation the breast area should not be treated. It is not known whether tacalcitol is excreted in human breast milk.

Effects on ability to drive and use machines

Not relevant.

Adverse reactions


The data given for frequency of adverse reactions is based on the following categories:

Very common (≥1/10)
Common (≥1/100 to <1/10)
Uncommon (≥1/1,000 to <1/100)
Rare (≥1/10,000 to 1/1,000)
Very rare (<1/10,000)
Not known (frequency cannot be estimated from the available data)

Metabolism and nutrition disorders

Frequency not known: Hypercalcaemia

Skin and subcutaneous tissue disorders

Rare: Skin irritation (e.g. burning, erythema), itching, contact dermatitis, worsening of psoriasis

Skin irritation and itching are generally mild and transient.

Cross-check medications

Review your medication to ensure that there are no potentially harmful drug interactions or contraindications.

Ask the Reasoner

Related medicines

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.